Actavis ($ACT) nabbed a big portfolio of branded products when it bought Forest Laboratories ($FRX) earlier this year. But it also inherited a quality-control problem. Forest expanded on a recall of Bystolic, one of its key drugs, adding another lot of more than 94,000 cartons of the blood pressure meds to the nationwide retrieval. It is the second recall in three months. Report